The US Federal Trade Commission held a two-day conference in Washington late last week to examine competition in the nation’s healthcare market, according to reports.
FTC Chairwoman Edith Ramirez launched the workshop early Thursday, telling attendees that “healthcare accounts for over 17 percent of GDP and study after study tells us that vigorous competition in healthcare markets reduces costs, improves quality and expands access to care for consumers.”
The regulator met to discuss regulatory oversight of the industry to promote innovation and increase price transparency in the industry.
The authority’s conference was open to the public; the FTC first requested public comment regarding competition in the healthcare market with a 50 questionnaire handout. Reports say the regulator is accepting public comment until the end of April.
Full Content: Health Data Management
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Nvidia and Microsoft Sued for Allegedly Undercutting AI Technology Patent Prices
Sep 5, 2024 by
CPI
White & Case Strengthens Antitrust and M&A Practices with New Partner Additions
Sep 5, 2024 by
CPI
Federal Judge Dismisses Antitrust Lawyers’ Fee Demand Over JetBlue-Spirit Deal
Sep 5, 2024 by
CPI
Boston Landlords Named as US Sues RealPage Over Alleged Rent-Inflating Practices
Sep 5, 2024 by
CPI
Judge to Weigh Landmark NCAA Settlement Proposal in Antitrust Lawsuit
Sep 5, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Canada & Mexico
Sep 3, 2024 by
CPI
Competitive Convergence: Mexico’s 30-Year Quest for Antitrust Parity with its Northern Neighbor
Sep 3, 2024 by
CPI
Competition and Digital Markets in North America: A Comparative Study of Antitrust Investigations in Mexico and the United States
Sep 3, 2024 by
CPI
Recent Antitrust Development in Mexico: COFECE’s Preliminary Report on Amazon and Mercado Libre
Sep 3, 2024 by
CPI
The Cost of Making COFECE Disappear
Sep 3, 2024 by
CPI